The treatment of keloids with intralesional bleomycin;Traitement des cheloides par infiltrations de bleomycine

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 12, 1996, Pages 791-794

  Bodokh, I ^a   Brun, P ^a  

^a centre hospitalier de Cannes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KELOID; MALE; ADOLESCENT; INTRALESIONAL DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; KELOID; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0030309284     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bodokh I. Brun P. Traitement des chéloïdes: procédé innovant. International Symposium on Plastic Surgery. Cannes 1994.
2. Bennett JM, Reich SD. bleomycin. Ann. Intern. Med. 1979; 90: 945-8.
3. Shelley WB, Shelley ED. Intralesional bleomycin sulfate therapy for warts: a novel bifurcated needle puncture technique. Arch. Dermatol. 1991; 127: 234-6.
4. Takigawa M, Oku T, Ginoza M, Yamada M, Yamamoto T, Kobayashi I. Treatment of viral warts with presure sensitive adhesive tape containing bleomycin sulfate. Arch. Dermatol. 1985; 121: 1108.
5. Sayama S, Tagami H. Treatment of keratoacanthoma with intralesional bleomycin. Br. J. Dermatol 1983; 109: 449-52.
6. Malmstöm M., Hietanen J., Sane J., Sysmäläinen M. Topical treatment of oral leukoplakia with bleomycin. Br. J. oral surg 1988; 26: 491-8.
7. Kazeem AA. The immunological aspects of keloid tumor formation. J. Surg. Oncol. 1988; 38: 16-8.
8. Berman B, Bieley Mc. Keloids. J. Am. Acad. Dermatol. 1995; 33: 117-23.
9. Aberger RP, Pizzurro BS, Meeker CA, Lask G, Matsuoka LY, Minor R. et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J. Invest. Dermatol. 1985; 84: 384-90.
10. Peltonen J, Hsiao LL, Jaakkla S, Sollberg S, Aumailley M, Timpl R. et al. Activation of collagen gene expression in keloids: co-localisation of type I and VI collagen and transforming growth factor β mRNA. J Invest. Dermatol. 1991; 97: 240-8.
11. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassali P. Tumor necrosis factor/cachectine plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 1989; 170: 655-63.
12. Templeton SF, Solomon AR, Swerlick RA. Intradermal bleomycin injection into normal humain skin. Arch. Dermatol. 1994; 130: 577-83.
13. Hendrick ST, Martens MF, Huyben CM, Wobbes T. Inhibition of basal and TGF-beta induced fibroblast collagen synthesis by antineoplastic agent. Implication for wound healing. Br. J. Cancer. 1993; 3: 545-50.
14. Villani F, Galimberti M, Barbieri A, Luisetti M, Bacchella L, Aprile C. Biochemical and fonctional marker of lung damage after bleomycin treatment. Monaldi. Arch. Chest. Dis. 1995; 50: 183-6.
15. Kikuchi K, Kadono T, Takehara K. Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatol. 1995; 190: 4-8.
16. Smith RE, Strieter RM, Zhang K, Phan SH, Standiford TJ, Lukacs NW, Kunkel SL. A role for CC chemokines in fibrotic lung disease. J. Leukoc. Biol. 1995; 57: 782-7.